CClinicalTrials.gg
Status unknownNCT04869774WATCHUpdated May 3, 2021

Wound And Symptom Tracking After Colorectal Surgery Using How2trak

An interventional study of How2Trak mobile application in Surgical Site Infection, Mobile Applications and Surgery--Complications, sponsored by University of Ottawa. Status unknown. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-05-03.

Sponsored by University of Ottawa · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Apr 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

The purpose of this study is to assess the feasibility of using a mobile application (app) called how2trak to improve people's experience, wound surveillance, and detection of surgical site infections (SSI) after colorectal surgery while reducing in-person interactions for patients during the COVID-19 pandemic.

This will inform the implementation of a full-scale trial to establish if surveillance of someone's incision and symptoms using how2trak improves SSI detection and management compared to standard care (involving a single post-operative surgery clinic visit).

The data collected will contribute to a broader dataset of people with SSI surveillance to be used in developing a clinical decision support system.

Read the detailed description

Background: Surgical site infections (SSI) are the most common nosocomial infection and occur in 16.3% of individuals undergoing colorectal surgery at our institution, the majority of which are identified after discharge from hospital. Patients concerned to have an SSI, generally present to the emergency department or surgery clinic. Both options for in-person interaction are costly to the healthcare system and patients, and increase their risk of COVID-19 exposure. A mobile application How2trak has proven to be beneficial for patients with complex wounds at our institution by facilitating at-home monitoring and virtual consultations.

Aim: This study aims to assess the feasibility of a randomized controlled trial to assess if How2trak can improve patients' experience, and detection of surgical site infections after colorectal surgery while reducing their risk of COVID-19 exposure.

Methods: In this single-center, prospective feasibility trial, eligible patients undergoing elective and semi-urgent colorectal surgery will be randomized to either standard care or How2trak post-operative monitoring of their incision, symptoms, and ostomy function. Patient self-assessments will be monitored by a nurse specialized in wound and ostomy care who will meet virtually with the patient as needed. The primary outcome is feasibility as measured by enrollment, randomization, H2T usability, data extraction, and resource capacity.

Results: We anticipate this work will help us to better understand the feasibility of using mobile technology to optimize patients' care after discharge from hospital after colorectal surgery. Virtual post-surgery wound and symptom monitoring could enhance patient experience, SSI detection, and reduce the risk of COVID-19 transmission. If this technology is feasible for our patient population and workflow, next steps will be to assess its effectiveness with a full-scale randomized controlled trial and explore additional applications including ostomy monitoring, patient education, and application in other surgical departments.

02

Conditions studied

  • Surgical Site Infection
  • Mobile Applications
  • Surgery--Complications
  • Colorectal Surgery
03

In context

Surgical Wound Infection

670 studies on the registry are indexed under Surgical Wound Infection; 141 are open to participants now.

This study's planned enrollment of 80 is below the median of 200 across 514 interventional studies indexed under Surgical Wound Infection.

Browse Surgical Wound Infection studies →

Lead sponsor

University of Ottawa is the lead sponsor of 123 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients must be 16 years of age or older who are being discharged from hospital after undergoing semi-urgent, urgent, or elective abdominal surgery by a colorectal surgeon at The Ottawa Hospital, and have provided informed consent to participate.

Patients enrolled in other clinical trials will still be candidates for this feasibility trial.

Clinicians using the how2trak app in this study will be considered study participants as well. They will be asked to complete the "Patient and Clinician Survey of Application". This survey addresses the experience with the use of the H2T app their feedback regarding usability is fundamental for future improvement.

Exclusion criteria

Exclusion Criteria:

  • Individuals will be excluded if less than 16 years of age; have no access or ability to use a mobile device; no cellular data/WiFi access; and/or cannot read and write in English.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    Virtual Monitoring

    Patients discharged from hospital after colorectal surgery will have virtual monitoring of their surgical incision and symptoms, using the mobile application How2Trak, post-operatively.

    Device: How2Trak mobile application

  • No intervention
    Standard of Care

    Patients discharged from hospital after colorectal surgery will receive standard of care with no virtual monitoring of their surgical incision and symptoms.

Interventions

  • DeviceHow2Trak mobile application

    Patients will undergo virtual monitoring of their incision and symptoms using the How2Trak application(app). Using the app, patients will be asked to answer a series of questions and photograph their surgical incision on post-operative day 3, 5, 7, 10, 20, and 30. Patient responses and photographs entered into the app will be reviewed within 72 hours by a trained Nurse Specialized in Wound, Ostomy and Continence. If a concern is identified the nurse will contact the patient to arrange a virtual visit using the how2trak app or notify the surgeon team (including colorectal surgeons and physician residents) in accordance with clinical discretion.

06

What researchers measure

Primary outcomes

  1. Capability for enrollment

    number of patients per month on average are enrolled in the study

    Time frame: 6 months

  2. Feasibility of the randomization processes

    proportion of patients randomized to the intervention or control group.

    Time frame: 6 months

  3. How2trak compliance

    Proportion of self-assessments completed by patients, on average.

    Time frame: 6 months

  4. How2trak usability, delivery and compliance

    The mean score for the patient and clinician survey of H2T application.

    Time frame: 6 months

  5. Monitoring of protocol deviation and safety

    The number and frequency of events when study activities diverge from the REB-approved protocol or are considered adverse events.

    Time frame: 6 months

  6. Feasibility of data extraction

    Proportion of patients for which all primary outcomes of the definitive trial are recorded. This includes the SSI incidence and severity and patient experience.

    Time frame: 6 months

  7. Resources and time required to conduct the feasibility trial will be assessed

    There is adequate administrative capacity, expertise, skills, space and time of the research team to complete the study.

    Time frame: 8 months

Secondary outcomes

  1. Surgical Site Infection (SSI) Rate

    Secondary outcomes will include SSI incidence and severity.

    Time frame: 6 months

  2. Patient experience

    Response to patient experience survey

    Time frame: 6 months

  3. Healthcare System Time

    Hours of in-person interactions with the healthcare system, including readmissions to hospital, ED visits, clinic visits etc.

    Time frame: 6 months

  4. Covid-19 infection Rate

    Confirmed COVID-19 infection within 30 days after surgery.

    Time frame: 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Valk HA, Garcia-Ochoa C, Fontaine Calder J, Miller T, Rashidi B, McIsaac C, Musselman R. A Mobile App for Wound and Symptom Surveillance After Colorectal Surgery: Protocol for a Feasibility Randomized Controlled Trial. JMIR Res Protoc. 2022 Jan 14;11(1):e26717. doi: 10.2196/26717. PubMed 34854816 ↗

Individual participant data

Plan to share: No — There are no plans to share IPD with other partners, collaborators, or researchers. Data will be captured through the assessments and/or photographs in the app and EPIC. Data sent from how2trak to TOH will be transferred through a secure, access-controlled folder within Office 365 including patient identifiers to allow for merging with EPIC data. Once the data files are merged, they will be deidentified. Only research personnel will have access to the study data. A data monitoring committee will not be developed given the minimal risk and small sample size of this feasibility trial.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 3, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04869774
Lead sponsor
University of Ottawa
Collaborators
The Ottawa Hospital, Health Outcomes Worldwide
Responsible party
Reilly Patrick Musselman (Principal Investigator, University of Ottawa) — Principal investigator
First posted
May 3, 2021
Start date
May 2021 (estimated)
Primary completion
Nov 2021 (estimated)
Completion
Feb 2022 (estimated)
Last update
May 3, 2021

Study contacts

Reilly Musselman, MD, MSc
Contact
rmusselman@toh.ca
613-798-5555
Heather Smith, MD,MSc
Contact
hsmit037@uottawa.ca
613-798-5555
Reilly Musselman, MD, MSc
principal investigator · University of Ottawa
Heather Smith, MD, MSc
principal investigator · University of Ottawa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion